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D4.9 Infrainguinal Disease-Endovascular Treatment
As with other interventions for CLI, the purpose of PTA is to salvage a functioning foot. Late
restenosis or occlusion after PTA may result in recurrent ulceration in some patients,' but it
rarely precludes subsequent surgery or compromises additional vascular segments. PTA can spare
saphenous vein for later use in the ipsilateral limb, the contralateral limb, or the coronary circu-
lation.
The categorical indications for endovascular treatment, based on clinical symptoms, include
patients in the grade I (severe claudication) grade II (rest pain ), and grade III (tissue loss) of the
Rutherford classification. For limb salvage indications, the effectiveness of transluminal angio-
plasry of the femoropopliteal arteries and the tib ioperoneal arteries should be considered togeth-
er rather than separately. This is because most patients with rest pain and tissue loss will have
multisegment occlusive disease, and effective treatment of both segments may be necessar y to
alleviate signs and symptoms.2,3 Furthermore, effective restoration of tibioperoncal artery blood
flow is believed by some to increase the durability of fernoropopliteal artery angioplasty.v
Unfortunately, few series have analyzed PTA of the fernoropopliteal and tibial segments togeth-
er.5,6,7 Angioplasry techniques have improved with time, allowing for technically successful per-
cutaneous recanalization of virtually all short lesions .8,9,10 However, appropriate selection of
anatomically suitable lesions remains the key to achieving acceptable results in patients with
infrainguinal occlusive disease and chronic limb-threatening ischemia (sec Recommendation 34,
p 5104).
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D 4.9.1 Factors Affecting the Outcome of Femoropopliteal Angioplasty
Percutaneous transluminal angioplasty has been applied to the superficial femoral and popliteal
artery segments for almost 35 years. Confusion and controversy still exist concerning outcomes,
because often the reporting of indications and results has not been standardized, and statistical
analysis has not been optimal. Varying the reporting criteria has been shown to result in as much
as a twofold difference in reported 5-year patency.U Many reported studies suffer from group-
ing of claudication and limb salvage patients; others from failure to stratify results,l2 and still
others from describing early experiences that antedate the latest developments in low-profile bal-
loon catheters and stcerablc, soft-tipped guidewires.l Ue
Claudication versus chronic critical limb ischemia
Despite the grouping of claudication and limb salvage patients in most fernoropopliteal PTA
series, analysis of subsets from these studies allows the clinical effectiveness of the method to be
estimated in patients with chronic CLI.
Lesion length
Currently, virtually all short femoropopliteal artery stenoses and occlusions can be percutaneous-
ly recanalized. Still, long lesion length is considered one of the £1.ctors detracting from both
technical success and durability of femoropopliteal PTA.15,16,17,18 Although recent analyses
often include a preponderance of patients with longer lesions,5,18,19,20 PTA of lesions longer
than 7 to 10 CI11 offers limited potency, 16,18 whereas those 3cm in length or smaller fare well
with PTA. 15,21
Stenosis versus occlusion
This variable was previously considered to be one of the most important determinants of both
technical success and durability of femoropopliteal PTA. Importantly, most symptomatic patients
with femoropopliteal disease presenting for angiography have occlusions rather than stenoses.
Technical failures, though uncommon, usually result from failure to cross tile lesion with a
guidewire and occur almost exclusively in cases of occlusion. Still, approximately up to 90% of
lesions up to 10 ern in length can be successfully traversed and dilated 8,22and even a higher
percentage success rate with longer lesions has been achieved." Nevertheless, relative to
stenoses, there is a difference in technical success tint lowers the starting point of the life-table
patency curve for occlusions. However, once an occlusion is crossed with a guidewire and suc-
cessfully dilated, it generally exhibits the same expected patency as that of a stenosis of equiva-
lent length, if all other factors are equal (ie, the life-table curves are paralle1).15,16,23,24 This
means that occlusion is a confounding variable that lowers tile initial technical success but that
has no other established impact on long-term patency.
Other target lesion morphological determinants
Concentric lesions respond better than eccentric lesions to PTA initially, and heavy lesion calcifi-
cation appears to exert a negative effect on success. IS,16 Posr-angioplasty residual stenosis pre-
dicts limited durability, and whether duplex ultrasonography is a modality, useful for making this
determination is COntroversiaI.2S,26,27
Runoffstatus
One of the most powerful predictors of long-term success that has great relevance in patients with
chronic CLI is the status of the runoff circulation. Patients with two- to three-vessel run-off have as
much as two to three times greater fernoropoliteal PTA patency than those with 0- to one-vessel run-
off at 2 to 3 years (71% to 78% vs 25% to 37%, respectivelyjl". 2J and at 5 years (36% to 53%vs 16%
to 31%, respective1y).28 A retrospective analysis of the literature with attention to run-off status indi-
cated 3- and 5-year patency results of 67% and 62%, respectively, for femoropopliteal stenosis and
good run-off; 53% and 48%, respectively, for occlusion and good runoff; 49%and 43%, respectively,
for stenosis and poor run-off; and 32% and 27%, respectively, for occlusion and poor run-off-?
8228 D4 Treatment of Critical Limb Ischemia
JOURNAL OF VASCULAR SURGERY
January 2000
Patient factors
Patient factors widely believed to adversely influence femoropopliteal artery PTA success are the
presence of diabetes mellitus and presentation for PTA with CLI rather than claudication.
19,21,28,30 However, it is likely that the effects of diabetes and CLI are statistically confounded
by run-off status and the extent of occlusive disease. Diabetic patients with good run-off fare
better than those with poor run-off after femoropopliteal PTA.31 Diabetic patients in whom
continuous run-off can be restored by tibioperoneal PTA also fare well.32 It is also likely that
patients with end-stage renal disease fare worse than the angioplasty population as a whole,
because of a combination of vascular anatomic factors and local metabolic factors; these patients
have been inadequately stratified in the PTA literature and may constitute up to 8% to 10% of
the limb salvage population in some instirutions.f
Summary offactors affecting the outcome offemoropopliteal angioplasty
Thus, although some have attempted to place a single value or range of values on the results of
femoropopliteal PTA, its efficacy is highly dependent on anatomic selection and, to a lesser
extent, patient selection. For patients with CLI, it is likely that only a minority-perhaps 5% to
35%-are candidates for PTA if selected for favorable anacomy.-. 10,33,34,35 PTA of proximal
popliteocrural obstructions to improve flow to collateral vessels in the absence of straight-line
flow to the foot will not help patients. 32 Laser-assisted angioplasty and rotablator athcrcctorny
of crural arteries does not improve the technical and clinical results as compared with PTA
alone.28,36,37,38,39,40,41,42,43 There is no body of published data on the use of laser-assisted PTA
and rotoblator atherectomy in infrapopliteallesions.
D 4.9.2 Femoropopliteal Angioplasty Results
The results of several large studies are summarized in Table 21, Endovascular Procedures for
Intermittent Claudication (p SI05). (See B 4.3.4, Femoropopliteal PTA, p S103; B 4.3.5,
Femoropoplireal Stents, p 5106.) They are presented in the intermittent claudication section
because this indication dominates the data (72% of subjects in the studies cited were patients
with intermittent claudication). These listed results must be viewed with caution, because
infrainguinal angioplasty depends heavily on patient selection factors. Nevertheless, by analyzing
subsets of patients described in these studies and others, one can estimate the clinical effective-
ness of infrainguinal PTA performed in patients with chronic CLI.
Table 22 (p S107) shows the results from selected studies by lesion length cut-off point. Again
these results are presented in the intermittent claudication section because this indication domi-
nates the data. Jeans et al21 found that stenoses smaller than 1 cm fared significantly better than
lesions larger than 1 ern at 5 years (primary patency, 76% vs. 50%, P < 0.05).21 Durability of
femoropopIiteaI PTA in a subgroup of 37 patients with stenoses and two- to three-vessel run-off
was 78% at 3 years (SE ± 9.4%); by contrast, occlusions with poor runoff showed a 25% patency
rate. Krepel et aIlS stratified results on durability and found that stenoses smaller than 2 cm
fared better at 5 years than stenoses longer than 2 em (primary patency, 77% vs. 54%), whereas
I-year patency rates with occlusions smaller than 3 cm was 93%, versus only 50% in occlusions
larger than 3 ern ;5 Gallina et aIl7 found that patients with occlusions larger than 3 cm and
poor distal run-off had elevated reocclusion rates compared with those who had focal stenoses
or occlusions smaller than 3 cm and two- to three-vessel runoff (primary patency, 37% vs 71 % at
2 years). 17 Currie et al44 defined lesions with a 5-cm cutoff; at 6 months, 10 of 17 short occlu-
sions or stenoses were patent (59%), whereas only 1 of23 long lesions were patent (4%).
Unfortunately, there was a 22% technical failure rate in this series, and the authors did not assess
the effect of run-off on patency.H
In comparing 0- to 2-cm and 2- to 5-cm lesions with those larger than 10 ern, Capek et aIl6
found highly significant differences in success (p = 0.007, p = 0.015). There were also strong
statistical trends when 0- to 2-cl11 lesions were compared with 2- to 5-cm and 5- to lO-cm
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lesions (p = 0.10, P = 0.06). Capek et al were unable to utilize Cox multivariate regression
because of sample size so they were unable to simultaneously analyze any run-off effect on these
stratified groups.J> Murray ct al, dividing his patients at 7 em, found that only 23% of long
femoropopliteal artery PTA were patent at 6 rnonths.If Because power estimates were not given,
it is likely that some nonsignificant differences were due to small sample size.
Adjunctive use ofstents in femoropoptiteallesions
The preponderance of patients in published series of femoropopliteal stents have been patients
with intermittent claudication, and although technical success is high, restenosis rates are consid-
erable. Reported mean stenosis rates are 30% at 1 year (range, 19% to 53%) and 40% at 3 years
(range, 28% to 82%) (see Table 23, p S10l; Table 24, p SI09). This series does not stratify
durability by clinical indication. Restenosis rates appear to be higher in distal femoropopliteal
segments or when lesions require multiple stents.45,46 Poor outflow and long occlusions appear
to increase the frequency of stent thrombosis.47,48
Because limb salvage indications are associated with poor run-off and more diffuse disease,
femoropopliteal stents probably do worse in CLI patients than in intermittent claudication, and
they would be expected to fare worse than the aggregate published stent population. However,
there is accumulating evidence that stents can play an important role in rescuing failed
femoropopliteal PTA attributable to PTA-induced dissection, elastic recoil, or thrombosis.49,50,51
There is little published evidence regarding the efficacy of tibial artery stents.
Repeated from p 5104
Recommendation 35: Treatment ofchoice for TIiSC type A and D femoropapliteallesions
Endovascular procedure is the treatment ofchoicefor type A lesions, and surgery is the proce-
dure ofchoicefor type D lesions.
D 4.9.3 Infrapopliteal Angioplasty
Clinical class
The universally accepted indication for infrapopliteal artery PTA is limb salvage. Some reported
series have comprised a significant proportion of claudicators. 4,52,64 Infrapopliteal PTA can be
used to salvage failing distal bypass grafts by restoring tibial artery outflow. 63 A number of pub-
lished reports have shown increased durability of femoropopliteal PTA in patients with good dis-
tal run-off; thus, some authors have recommended tibial angioplasty as an adjunct to
femoropopliteal PTA performed for either claudication or limb salvagewhen calf run-off is poor. 4
Diabetes and end-stage renal disease
Diabetes is present in 63% to 91% of patients undergoing tibial angioplasty for limb salvage indi-
cations. Although most of these patients present with three-vessel calf occlusive disease, there is
usually reconstitution of at least one pedal artery. Patients with end-stage renal disease (who
are often diabetic) appear to be the most difficult group to treat because they have very diffuse
disease with more involvement of the distal and pedal vessels, and because there is heavier arteri-
al calcification. The presence of end-stage renal disease (ESRD) probably has a negative prog-
nostic effect on the durability of tibial and fernoropopliteal PTA, but it has not been accounted
for in published angioplasty series. 3,53
Cardiovasc'ular comorbidity
The median age of patients undergoing tibial angioplasty in published series is approximately 69
years. These high-risk patients almost always have associated cardiac or cerebrovascular disease:
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hypertension, chronic renal insufficiency, and history ofTIA or stroke are common.s? Five-year
survival in patients with limb salvage indications for surgical or percutaneous intervention is only
approximately 50%; mortality is usually attributable to coronary artery disease or stroke? The
procedure-related mortality is lower with PTA than with bypass surgery. More than 1,200
patients are reported in the literature.V
Lesion length and run-offstatus
The ideal tibial lesion is focal, with good run-off distally. Stenoses appear to have a better tech-
nical success rate than occlusions. Only approximately 20% to 30% of patients with tibial disease
have anatomy favorable for PTA.3,10 Severe three-vessel disease is nearly universal' in limb sal-
vage patients; anatomy favorable for tibial PTA, if present, is usually seen in one or two vessels.
A concomitant procedure, usually fernoropopliteal artery PTA, is necessary in most patients
undergoing tibial angioplasty because of the predominance of multilevel occlusive disease; thus,
the results of fernoropopliteal PTA and tibial PTA are closely associated. Restoration of straight-
line flow to the pedal arch by PTA in one or more tibial arteries is necessary for clinical success;
dilatation of a proximal lesion when the distal artery is severely diseased will not yield lasting
clinical benefit in limb salvage patients.V. 63,64 This finding has since been corroborated byoth-
ers, Crural disease in patients with long-standing diabetes may, in rare cases, be the sole determi-
nant of CLI, despite the absence of aortoiliac or femoropopliteal disease. A small subset of these
patients may be suitable for PTA. It is probable that the status of the pedal arch-never looked
at in infrainguinal angioplasty studies-also affects the outcome of distal angioplasty. Careful
patient selection is thus important for both technical and clinical success.
Results ofendavascular treatment of infrapopliteallesions
Recent published technical success rates of infrapopliteal artery PTA using small vessel balloons
have been excellent, between 86% and 100%. Major complications have been reported in 2% to
6% of cases, most frequently puncture site hematomas and vessel occlusions. Iatrogenic vascular
occlusion usually responds to local thrombolysis. Limb salvage has been reported to be between
60% and 86% at 2 years and appears to be dependent on anatomic factors. For example, Bakal et
al32 found an 80% limb salvage rate in patients with "straight line flow" to the foot in at least
one tibial vessel after PTA, whereas limb salvage fell to 0% when distal outflow was obstructed.V
In a later group of patients at the same institution, infrainguinal PTA performed for long-seg-
ment, more diffuse disease in patients with poor surgical options had a I-year primary patency as
low as 15%, confirming the need for careful anatomic selection. Appropriate post-PTA surveil-
lance with secondary intervention appears to significantly prolong the patency of tibial PTA. 52
In recent years, several reports with sufficient long-term follow-up of PTA in infrapoplireal
lesions have appeared in the literature (Table 51). Only technical success and limb salvage fig-
ures are given, because patency of one of three crural vessels is impossible to determine by ABPI
or other indirect measurements, especially because proximal revascularization procedures may
have been done concomitantly.
D 4.9.4 Summary
Substantial experience demonstrating the effectiveness and safety of infrainguinal angioplasty has
been accumulated. Although differences in reporting make it difficult to easily estimate the true
effectiveness of infrainguinal PTA, a consensus about its effectiveness can be obtained by critical
analysis of the existing reports. Technical success rates now approach 95% to 100%. Anatomic
selection is most important. Patients with focal disease and restorable runoff will generally bene-
fit; conversely, patients with diffuse disease and poor run-off will not. Unfortunately, because of
the presence of diffuse disease in chronic CLI, endovascular techniques are only applicable in a
small portion of CLI patients. For femoropopliteal PTA, 50% to 77% of anatomically selected
patients will show clinical benefit at 2 years. Tibial PTA has generally been reserved for limb sal-
vage patients, and with appropriate patient selection, 2-year limb salvage rates of approximately
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Table 51: Results of PTA in infrapopliteal lesions (from a review by Wagner & Rager55)
eLI Diabetes Technical %Limb salvage
Author Limbs (%) (%) success (%) (jollow-u] pe"iod)
Schwarten & Cutcliff, 1988 10 114 100 60 97 86 (24 rna)
Lofberg ct al, 199656 86 100 74 88 75 (24 mol
Matsi et al, 19935 84 100 77 83 52 (24 mol
Hauser ct al, 199657 47 100 93 80 77 (24 mol
Saab et al, 199258 14 100 69 100 79 (19 rna)
Buckcnham ct al, 199359 14 100 38 100 85 (8 mol
Durham er al, 199460 14 100 100 100 77 (17 mol
Brown ct al, 198861 11 100- 91 82 73 (8 mol
Bakal et al, 199032 57 98 85 78 NA
Wagner & Klose, 199762 87 93 64 92 71 (12 mol
Brown et al, 199363 55 84 64 95 53 (24 mol
Bull et a.l, 199264 168 76 52 100 85 (24 mol
Bolia er al, 199465 24 71 43 86* NA
Wagner et al, 199 37 158 68 46 95 88 (17 mol
Starck et aI, 198437 46 67 NA 76 NA
Dorros et al, 199066 151 53 46 90 NA
Sivanathan et al, 19946 41 53 13 96 NA
Varry et al, 199552 40 50 45 98 77 (12 mol
Horvath et al, 19904 71 42 35 96 NA
*Subintima.l angioplasty.
80% can be expected. Close surveillance and early reintervention will probably increase the
effectiveness of percutaneous treatment methods.
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D 4.10 Infrainguinal Disease-Preferred Therapeutic Options
Hunink et a11,2 performed key decision and cost-effectiveness studies on femoropopliteal dis-
ease, by using a range ofvalucs found in the literature and performing multiway sensitivity
analyses. In their 1995 study, data were included from 26 selected studies published after 1985,
involving 4,800 PTA procedures and 4,511 surgical bypasses. Quality-adjusted life-years
(QALY) were used as the main effectiveness measure. The pooled 5-year PTA patency results
were calculated for subgroups by lesion type (stenosis vs occlusion) and indication (disabling
claudication vs chronic critical limb ischemia); surgical bypass subgroups were based on indica-
tion, conduit type, and distal anastomosis site (AK./BK).1 Notably, the potential covariates of
lesion length and calf runoff were not analyzed, in part because of the inadequate data descrip-
tors provided in the original reports. (The authors noted that because there was a statistically
significant association between poor runoff and eLI in an earlier paper, 2 either model could be
used.) Stenting or other adjunctive techniques were not considered. This group concluded that
for fernoropopliteal stenosis and CLI, PTA should be the first treatment modality, but for
femoropopliteal occlusions and CLI, surgical bypass is preferable.
Pertinent to the recommendation to attempt PTA first in anatomically favorable lesions, Wilson
et al3 found that for 100 femoropopliteal artery lesions, a failed PTA did not place the patient at
